TITLE 22.EXAMINING BOARDS

Part 14. TEXAS OPTOMETRY BOARD

Chapter 280. THERAPEUTIC OPTOMETRY

22 TAC §280.5

The Texas Optometry Board proposes amendments to §280.5, concerning Prescription and Diagnostic Drugs for Therapeutic Optometry in order to incorporate changes made in the Texas Pharmacy Act regarding dispensing instructions to pharmacies on product substitution. Amendments by the Pharmacy Board to 22 TAC §309.3 have been incorporated into §280.5 so that licensees of the Board may be in compliance with the Texas Pharmacy Act. The proposed amendments correct requirements for written, electronically, and verbally transmitted prescriptions. Citations to the Optometry Act have also been corrected.

Chris Kloeris, Executive Director of the Texas Optometry Board, has determined that for the first five-year period the amendments are in effect, there will be no fiscal implications for state and local governments as a result of enforcing or administering the amendments.

Chris Kloeris also has determined that for each of the first five years the amendments are in effect, the public benefit anticipated as a result of enforcing the amendments is that the public will receive from their pharmacists the drugs as prescribed by their therapeutic optometrist. It has also been determined that the amendments will not impose any additional costs to the persons affected by the rule since existing prescription forms may still be used. No additional costs are foreseen for small or micro business.

Comments on the proposal may be submitted to Chris Kloeris, Executive Director, Texas Optometry Board, 333 Guadalupe Street, Suite 2-420, Austin, Texas 78701-3942. The deadline for furnishing comments is 30 days after publication in the Texas Register .

The amendments are proposed under the Texas Optometry Act, Texas Occupations Code, §351.151 and the Texas Pharmacy Act §562.015. The Texas Optometry Board interprets §351.151 as authorizing the adoption of procedural and substantive rules for the regulation of the optometric profession and §562.015 as authorizing the board to direct licensees to follow statutory dispensing directives for the communication of substitution instructions to pharmacists.

No other section is affected by the amendments.

§280.5.Prescription and Diagnostic Drugs for Therapeutic Optometry.

(a) A therapeutic optometrist may administer and prescribe any drug authorized by §351.358(a) and (b)(1) of the [ Texas Optometry ] Act [ Articles 4552-1.02 and 1.03, as amended by House Bill 1051, 76th Legislature, Regular Session ].

(b) To prohibit substitution of a generically equivalent drug product on a written prescription drug order, a therapeutic optometrist must write across the face of the written prescription, in the therapeutic optometrist's own handwriting, "brand necessary" or "brand medically necessary." [ As specified in the Texas Pharmacy Act (§562.008 and §563.002, Texas Occupations Code), written prescriptions shall be on a form which contains two signature lines of equal prominence, side by side, at the bottom of the form. Under either signature line shall be printed clearly the words "product selection permitted", and under the other signature line shall be printed clearly the words "dispense as written." A therapeutic optometrist shall communicate dispensing instructions to a pharmacist by signing on the appropriate line. ] If the therapeutic optometrist does not clearly indicate "brand necessary" or "brand medically necessary," [ that the prescription drug shall be dispensed as ordered, ] the pharmacist may substitute a generically equivalent drug product in compliance with the Texas Pharmacy Act , §562.008 and §563.002 of the Texas Occupations Code, and §309.3 of this title .

(c) (No change.)

(d) The prescribing therapeutic optometrist issuing verbal or electronic [ oral ] prescription drug orders to a pharmacist shall furnish the same information required for a written prescription, except for the written signature. If the therapeutic optometrist does not clearly indicate [ that the prescription drug shall be dispensed as ordered by writing across the face of the written prescription, in the therapeutic optometrist's own handwriting, the phrase ] "brand necessary" or "brand medically necessary," when communicating the prescription to the pharmacist, the pharmacist may substitute a generically equivalent drug product in compliance with the Texas Pharmacy Act and §309.3 of this title.

(e) - (j) (No change.)

This agency hereby certifies that the proposal has been reviewed by legal counsel and found to be within the agency's legal authority to adopt.

Filed with the Office of the Secretary of State on March 18, 2003.

TRD-200301799

Chris Kloeris

Executive Director

Texas Optometry Board

Earliest possible date of adoption: May 4, 2003

For further information, please call: (512) 305-8502